Local Allergic Rhinitis Clinical Trial
Official title:
Assessment of the Effectiveness of a Dermatophagoides Pteronyssinus Extract, Rated in Units of Mass and Administered Subcutaneously for the Treatment of Local Allergic Rhinitis. Randomized, Double-blind, Placebo-controlled Study.
To evaluate the efficacy of an extract of Dermatophagoides pteronyssinus versus placebo in
the treatment of local allergic rhinitis. The primary efficacy endpoint is the reduction in
symptom scores and medication use in the active group compared to placebo.
The influence of treatment in "in vitro" and "in vivo" objective parameters was also
assessed.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04544774 -
The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy
|